[DOI] [PMC free article] [PubMed] [Google Scholar] 142.Strbe S., Smoday I.M., Krezic I., Kalogjera L., Vukovic V., Zizek H., Gojkovic S., Vranes H., Barisic I., Sikiric S., et al
These sources include peer-reviewed studies and information from agencies such as the FDA and USDA, and the National Academy of Medicine
For example, the current recommendations for the management of children with Kawasaki disease include treatment with high-dose aspirin in the acute phase, and low-dose aspirin during the period of thrombocytosis
Federal authorities also recently indicted a Utah doctor, alleging comparable misconduct
J Am Soc Nephrol
Long-term clinical outcome, therapy and mild mitochondrial dysfunction in hyperprolinemia